It has been already more than two years since the world was shocked by COVID-19. With countless infections and deaths worldwide, there are cases reported regarding long-term effects in some patients.
The Long Covid project, led by HUS Helsinki University Hospital, aims to identify and understand the long-term effects of COVID-19 and the underlying mechanisms of its persistent symptoms to provide appropriate treatment to patients who are suffering from it.
Lipotype is one of the members of the Long Covid consortium running the Long Covid project, which also includes the University of Helsinki, Finnish Institute of Molecular Medicine (FIMM), and major EU research institutes in Switzerland, Netherlands, Germany, Estonia and Italy. The European Commission has provided a contribution of € 6.55 million fund to thisconsortium.
Lipotype utilizes lipidomics technology to understand the long-term impact of coronavirus at the lipid level. Based on this understanding, Lipotype participates in this innovation that can more systematically manage the long-term impact of COVID-19 as well as other possible future infectious diseases.